Jeremy M. Levin
Chairman
Ovid Therapeutics Inc. (OVID)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeremy M. Levin
Jeremy M. Levin is recorded as Chairman at Ovid Therapeutics Inc. (OVID). Ovid Therapeutics Inc. reported in an 8-K filed November 12, 2025 that Jeremy M. Levin was appointed Executive Chairman, effective January 1, 2026. The proxy statement of Ovid Therapeutics Inc. reports total compensation of $1,934,699 for Jeremy M. Levin in fiscal 2025, including a base salary of $644,054. Disclosed compensation is on record for 7 fiscal years.
“Ms. Alexander succeeds Dr. Jeremy M. Levin, who has served as Chief Executive Officer of the Company since 2015 and will continue with the Company as Executive Chairman following the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2015-01-01–present
-
2015-01-01–2023-04-27
Last confirmed by a filing; no departure on record
-
Start not stated–2025-05-22
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ovid Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Margaret "Meg" Alexander CEO, COO, Board Member
- Margaret Alexander CEO, COO, Board Member
- Charles Carter CFO
- Jeffrey Rona CFO, Chief Accounting Officer
- Anna Greka, M.D., Ph.D. Board Member
- Dr. Kevin Fitzgerald, Ph.D. Board Member
- Dr. Robert Michael Poole Board Member
- Stelios Papadopoulos, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ovid Therapeutics Inc. (OVID) | DPhil, MB BChir Executive Chairman and Former Chief Executive Officer | $644,054 | $1,934,699 |
| 2024 | Ovid Therapeutics Inc. (OVID) | DPhil, MB BChir Executive Chairman and Former Chief Executive Officer | $625,296 | $2,774,102 |
| 2023 | Ovid Therapeutics Inc. (OVID) | DPhil, MB BChir Chief Executive Officer | $625,296 | $2,136,546 |
| 2022 | Ovid Therapeutics Inc. (OVID) | DPhil, MB BChir Chief Executive Officer | $607,083 | $3,127,762 |
| 2021 | Ovid Therapeutics Inc. (OVID) | DPhil, MB BChir Chief Executive Officer | $583,734 | $847,069 |
| 2020 | Ovid Therapeutics Inc. (OVID) | DPhil, MB BChir. Chief Executive Officer | $560,000 | $2,135,499 |
| 2019 | Ovid Therapeutics Inc. (OVID) | DPhil, MB BChir. Chief Executive Officer | $530,450 | $3,008,980 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.